Dr. Casella's #1 tip for managing dry eye

Video

Optometry Times'® Chief Optometric Editor Ben Casella, OD, FAAO, gives his number 1 tip for managing DED.

Optometry Times®' Chief Optometric Editor Ben Casella, OD, FAAO, shares his top tip for managing dry eye disease (DED).

Key takeaways:

  • Dry eye disease is a disease
  • Patient history never ends
  • Stain more ocular surfaces
  • Express meibomian glands

This transcript has been lightly edited for clarity.

What is my number one tip for dry management for the eye doctor? I would say it's going to be the consummation of several tips, briefly.

I would say that dry eye disease is a disease. This is not just some ocular surface, artificial tear thing. Tears certainly have their place, but this is a disease. It has an ICD code, just like diabetes, just like glaucoma, just like cataracts. And we are poised to take on dry eye; optometry is poised for this.

Patient history never ends. If you're having a difficult refraction and a patient seeing, and then they blink and whoa, I can't see a darn thing, we need to pull the proctor back, we need to look at the ocular surface.

We need to stain more ocular surfaces than we do. We need to stain patients who may not be having any symptoms at all, or maybe having symptoms that they're not telling us about. The ocular surface will speak to you, we just have to look at it.

And maybe the most important tangible tip that I could give would be to express meibomian glands. And not just the ones on the lower lid, we need to express and see what's coming out of those glands. Is it a nice clear oil or is it toothpaste? And that's going to really drive our management, that's going to really tailor our therapy accordingly. Don't forget to express glands.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, ponders what she would like to see develop as both a researcher and a clinician in the dry eye space.
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, discussed research that utilized IQVIA longitudinal prescription claims data from September through November 2023, coinciding with Miebo's FDA approval in September.
Dr Julie Poteet reports on patient-reported outcomes using lipid-containing artificial tear
Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
© 2025 MJH Life Sciences

All rights reserved.